Literature DB >> 22871890

Genes and environment: novel, functional polymorphism in the human cathepsin L (CTSL1) promoter disrupts a xenobiotic response element (XRE) to alter transcription and blood pressure.

Nzali Mbewe-Campbell1, Zhiyun Wei, Kuixing Zhang, Ryan S Friese, Manjula Mahata, Andrew J Schork, Fangwen Rao, Stephane Chiron, Nilima Biswas, Hyung-Suk Kim, Sushil K Mahata, Jill Waalen, Caroline M Nievergelt, Vivian Y Hook, Daniel T O'Connor.   

Abstract

BACKGROUND: Cathepsin L (CTSL1) catalyzes the formation of peptides that influence blood pressure (BP). Naturally occurring genetic variation or targeted ablation of the Ctsl1 locus in mice yield cardiovascular pathology. Here, we searched for genetic variation across the human CTSL1 locus and probed its functional effects, especially in the proximal promoter. METHODS AND
RESULTS: Systematic polymorphism discovery by re-sequencing across CTSL1 in 81 patients uncovered 38 genetic variants, five of which were relatively common (MAF >5%), creating a single linkage disequilibrium block in multiple biogeographic ancestries. One of these five common variants lay in a functional domain of the gene: promoter C-171A (rs3118869), which disrupts a predicted xenobiotic response element (XRE; match C>A). In transfected CTSL1 promoter/luciferase reporter plasmids, C-171A allele influenced transcription (C>A, P = 3.36E-6), and transcription was also augmented by co-exposure to the aryl hydrocarbon receptor (AHR) complex (AHR:ARNT) in the presence of their ligand dioxin (P = 6.81E-8); allele (C vs. A) and AHR:ARNT/dioxin stimulus interacted to control gene expression (interaction P = 0.033). Endogenous Ctsl1, Ahr, and Arnt transcripts were present in chromaffin cells. Promoter functional C-171A genotype also predicted hypertension (P = 1.0E-3), SBP (P = 4.0E-4), and DBP (P = 3.0E-3), in an additive pattern for diploid genotypes (A/A > C/A > C/C) in 868 patients, and the results were extended by validation analysis into an independent population sample of 986 patients.
CONCLUSION: We conclude that common genetic variation in the proximal CTSL1 promoter, especially at position C-171A, is functional in cells, and alters transcription so as to explain the association of CTSL1 with BP in vivo. At the XRE, endogenous genetic variation plus exogenous aryl hydrocarbon stimulation interact to control CTSL1 gene expression. These results unveil a novel control point whereby heredity and environment can intersect to control a complex trait, and point to new transcriptional strategies for intervention into transmitter biosynthesis and its cardiovascular consequences.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22871890      PMCID: PMC3478326          DOI: 10.1097/HJH.0b013e328356b86a

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  23 in total

1.  Antihypertensive treatments obscure familial contributions to blood pressure variation.

Authors:  Jisheng S Cui; John L Hopper; Stephen B Harrap
Journal:  Hypertension       Date:  2003-02       Impact factor: 10.190

Review 2.  Applied bioinformatics for the identification of regulatory elements.

Authors:  Wyeth W Wasserman; Albin Sandelin
Journal:  Nat Rev Genet       Date:  2004-04       Impact factor: 53.242

3.  Haploview: analysis and visualization of LD and haplotype maps.

Authors:  J C Barrett; B Fry; J Maller; M J Daly
Journal:  Bioinformatics       Date:  2004-08-05       Impact factor: 6.937

4.  Defining the CREB regulon: a genome-wide analysis of transcription factor regulatory regions.

Authors:  Soren Impey; Sean R McCorkle; Hyunjoo Cha-Molstad; Jami M Dwyer; Gregory S Yochum; Jeremy M Boss; Shannon McWeeney; John J Dunn; Gail Mandel; Richard H Goodman
Journal:  Cell       Date:  2004-12-29       Impact factor: 41.582

5.  Diminished circadian variation in heart rate variability before surgery in patients developing postoperative atrial fibrillation.

Authors:  L Jidéus; M Ericson; M Stridsberg; L Nilsson; P Blomström; C Blomström-Lundqvist
Journal:  Scand Cardiovasc J       Date:  2001-09       Impact factor: 1.589

6.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice.

Authors:  J D Thompson; D G Higgins; T J Gibson
Journal:  Nucleic Acids Res       Date:  1994-11-11       Impact factor: 16.971

Review 7.  Mapping quantitative trait loci using linkage disequilibrium: marker- versus trait-based methods.

Authors:  Albert Tenesa; Peter M Visscher; Andrew D Carothers; Sara A Knott
Journal:  Behav Genet       Date:  2005-03       Impact factor: 2.805

8.  Role of the aryl hydrocarbon receptor nuclear translocator protein in aryl hydrocarbon (dioxin) receptor action.

Authors:  M R Probst; S Reisz-Porszasz; R V Agbunag; M S Ong; O Hankinson
Journal:  Mol Pharmacol       Date:  1993-09       Impact factor: 4.436

9.  Both rare and common polymorphisms contribute functional variation at CHGA, a regulator of catecholamine physiology.

Authors:  Gen Wen; Sushil K Mahata; Peter Cadman; Manjula Mahata; Sajalendu Ghosh; Nitish R Mahapatra; Fangwen Rao; Mats Stridsberg; Douglas W Smith; Payam Mahboubi; Nicholas J Schork; Daniel T O'Connor; Bruce A Hamilton
Journal:  Am J Hum Genet       Date:  2004-01-12       Impact factor: 11.025

10.  Linkage disequilibrium analysis of biallelic DNA markers, human quantitative trait loci, and threshold-defined case and control subjects.

Authors:  N J Schork; S K Nath; D Fallin; A Chakravarti
Journal:  Am J Hum Genet       Date:  2000-10-13       Impact factor: 11.043

View more
  6 in total

1.  Structurally distinct polycyclic aromatic hydrocarbons induce differential transcriptional responses in developing zebrafish.

Authors:  Britton C Goodale; Susan C Tilton; Margaret M Corvi; Glenn R Wilson; Derek B Janszen; Kim A Anderson; Katrina M Waters; Robert L Tanguay
Journal:  Toxicol Appl Pharmacol       Date:  2013-05-05       Impact factor: 4.219

2.  Ligand-Specific Transcriptional Mechanisms Underlie Aryl Hydrocarbon Receptor-Mediated Developmental Toxicity of Oxygenated PAHs.

Authors:  B C Goodale; J La Du; S C Tilton; C M Sullivan; W H Bisson; K M Waters; R L Tanguay
Journal:  Toxicol Sci       Date:  2015-07-03       Impact factor: 4.849

Review 3.  Germline Genetic Variants of Viral Entry and Innate Immunity May Influence Susceptibility to SARS-CoV-2 Infection: Toward a Polygenic Risk Score for Risk Stratification.

Authors:  Vince Kornél Grolmusz; Anikó Bozsik; János Papp; Attila Patócs
Journal:  Front Immunol       Date:  2021-03-08       Impact factor: 7.561

Review 4.  Cathepsin L in COVID-19: From Pharmacological Evidences to Genetics.

Authors:  Caio P Gomes; Danilo E Fernandes; Fernanda Casimiro; Gustavo F da Mata; Michelle T Passos; Patricia Varela; Gianna Mastroianni-Kirsztajn; João Bosco Pesquero
Journal:  Front Cell Infect Microbiol       Date:  2020-12-08       Impact factor: 5.293

5.  Genetic Control of Human Infection with SARS-CoV-2.

Authors:  A N Kucher; N P Babushkina; A A Sleptcov; M S Nazarenko
Journal:  Russ J Genet       Date:  2021-07-03       Impact factor: 0.581

6.  Inference of human continental origin and admixture proportions using a highly discriminative ancestry informative 41-SNP panel.

Authors:  Caroline M Nievergelt; Adam X Maihofer; Tatyana Shekhtman; Ondrej Libiger; Xudong Wang; Kenneth K Kidd; Judith R Kidd
Journal:  Investig Genet       Date:  2013-07-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.